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Carbohydrate-binding modules such as CBM41d aid in the capture of starch by Eubacterium rectale in the 
human intestine.  
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Gut bacteria attach to dietary fiber such as starch via carbohydrate binding modules (CBMs). 
Here we demonstrate that a cell surface starch-degrading enzyme Amy13K from the prominent 
gut bacterium Eurbacterium rectale harbors five CBMs that have different specificities and 
affinity for starch. The specificity of the Amy13K CBMs provides a molecular rationale for why E. 
rectale is only able to process certain types of dietary starch in the human large intestine.  
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Novel	carbohydrate	binding	modules	in	the	surface	anchored	α-amylase	of	Eubacterium	rectale	
provide	a	molecular	rationale	for	the	range	of	starches	used	by	this	organism	in	the	human	gut.	
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Summary	
Gut	bacteria	recognize	accessible	glycan	substrates	within	a	complex	environment.	Carbohydrate	
binding	modules	(CBMs)	of	cell-surface	glycoside	hydrolases	often	drive	binding	to	the	target	substrate.	
Eubacterium	rectale,	an	important	butyrate-producing	organism	in	the	gut,	consumes	a	limited	range	
of	substrates,	including	starch.	Host	consumption	of	resistant	starch	increases	the	abundance	of	E.	
rectale	in	the	intestine,	likely	because	it	successfully	captures	the	products	of	resistant	starch	
degradation	by	other	bacteria.	Here	we	demonstrate	that	the	cell	wall	anchored	starch-degrading	α-
amylase,	Amy13K	of	E.	rectale	harbors	five	CBMs	that	all	target	starch	with	differing	specificities.	
Intriguingly	these	CBMs	efficiently	bind	to	both	regular	and	high	amylose	corn	starch	(a	type	of	
resistant	starch),	but	have	almost	no	affinity	for	potato	starch	(another	type	of	resistant	starch).	
Removal	of	these	CBMs	from	Amy13K	reduces	the	activity	level	of	the	enzyme	towards	corn	starches	
by	~40-fold,	down	to	the	level	of	activity	towards	potato	starch,	suggesting	that	the	CBMs	facilitate	
activity	on	corn	starch	and	allowing	its	utilization	in	vivo.	The	specificity	of	the	Amy13K	CBMs	provides	a	
molecular	rationale	for	why	E.	rectale	is	able	to	only	use	certain	starch	types	without	the	aid	of	other	
organisms.		
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Introduction	
The	human	gut	microbiota	consists	of	trillions	of	individual	bacteria	and	the	interaction	of	this	dense	
microbial	population	with	our	diet	and	other	environmental	factors	is	an	important	determinant	of	our	
health.	A	healthy	microbiome	is	protective	against	a	number	of	conditions	including	colon	cancer	
(Zackular	et	al.,	2013),	inflammatory	bowel	disease	(De	Cruz	et	al.,	2015,	Rajilic-Stojanovic	et	al.,	2013),	
diabetes	(Forslund	et	al.,	2015)	and	obesity	(Ridaura	et	al.,	2013).	Saccharolytic	gut	bacteria	offer	
particular	benefits,	persisting	in	the	host	through	the	fermentation	of	fiber,	carbohydrates	that	human	
enzymes	are	unable	to	process	(Shanahan	et	al.,	2017).	One	prominent	fiber	in	the	human	diet	is	
resistant	starch,	starches	that	for	a	variety	of	reasons	are	indigestible	by	human	enzymes,	but	are	
susceptible	to	attack	by	certain	microorganisms	(Birt	et	al.,	2013).	Uncooked	potato	starch	is	one	such	
resistant	starch	as	it	adopts	an	alternative	crystal	structure,	known	as	the	B-type	structure,	compared	
to	the	more	easily	digestible	wheat	and	corn	starches	(Imberty	et	al.,	1991).	In	corn,	certain	mutations	
result	in	a	higher	relative	abundance	of	amylose	in	the	starch	granules.	This	high	amylose	corn	starch	
also	adopts	the	B-type	crystalline	structure	and	is	a	resistant	starch	(Gallant	et	al.,	1992).	The	end	result	
of	resistant	starch	and	other	carbohydrate	fermentation	in	the	gut	is	often	organic	acids,	particularly	
the	short	chain	fatty	acids	(SCFA)	acetate,	propionate,	and	butyrate	(Rios-Covian	et	al.,	2016).		
While	SCFAs	have	been	shown	to	influence	our	physiology	(Berggren	et	al.,	1996,	Wong	et	al.,	2006,	
Boets	et	al.,	2016),	butyrate	has	been	particularly	noted	for	its	health	promoting	effects	(Guilloteau	et	
al.,	2010).	This	SCFA	can	provide	as	much	as	10%	of	our	daily	caloric	intake	(McNeil,	1984)	and	it	is	the	
preferred	energy	source	of	colonocytes	(Roediger,	1980).	Butyrate	increases	the	rate	of	proliferation	of	
colonocytes	and	strengthens	tight	junctions	(Wang	et	al.,	2012),	improving	gut	barrier	function.	It	
increases	the	rate	of	apoptosis	for	malignant	cells,	protecting	against	colon	cancer	(Fung	et	al.,	2012).	
Butyrate	also	downregulates	the	expression	of	pro-inflammatory	cytokines,	leading	to	lower	levels	of	
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inflammation	in	the	gut	(Nastasi	et	al.,	2015).	When	processed	in	the	liver,	butyrate	shifts	glucose	
metabolism	towards	storage	as	glycogen	(Beauvieux	et	al.,	2008),	thereby	protecting	against	the	
development	of	diabetes.	Thus,	butyrate	is	clearly	a	critical	regulator	of	health	making	it	important	to	
understand	the	unique	physiology	of	the	bacteria	responsible	for	its	production.		
One	of	the	most	prominent	groups	of	butyrate-producing	organisms	in	the	gut	is	the	cluster	XIVa	
clostridia,	exemplified	by	one	of	their	most	abundant	members,	Eubacterium	rectale.	This	Gram	
positive	organism	has	long	been	recognized	as	a	dominant	species	in	the	human	gut	(Gossling	&	Slack,	
1974)	and	a	core	member	of	the	healthy	microbiome	(Tap	et	al.,	2009).	E.	rectale	decreases	in	
abundance	in	a	number	of	disease	states,	including	obesity	(Haro	et	al.,	2016),	inflammatory	bowel	
disease	(Kang	et	al.,	2010,	Rajilic-Stojanovic	et	al.,	2013),	diabetes	(Qin	et	al.,	2012)	and	cystic	fibrosis	
(Bruzzese	et	al.,	2014).	Intriguingly,	E.	rectale	levels	are	found	to	increase,	along	with	butyrate	levels,	in	
diets	rich	in	resistant	starch	(Martínez	et	al.,	2010,	Martínez	et	al.,	2013).	However,	in	vitro	studies	
indicate	that	it	is	unable	to	directly	use	resistant	starch,	though	it	grows	robustly	in	the	presence	of	a	
primary	resistant	starch	degrader	such	as	Ruminococcus	bromii	(Ze	et	al.,	2012).	Our	recent	study	of	
the	cell	wall	and	membrane	proteome	of	E.	rectale	when	grown	on	starch	as	compared	to	glucose,	
revealed	that	two	ABC	transporters	that	target	different	maltooligosaccharides,	along	with	two	
amylases	were	strongly	upregulated	in	the	presence	of	starch.	Thus	we	proposed	a	model	by	which	the	
larger	cell	surface	amylase	EUR_21100	plays	a	crucial	role	in	the	organism’s	growth	on	starch,	cleaving	
starch	molecules	into	maltotetraose	and	larger	oligosaccharides,	which	is	directly	bound	by	the	ABC	
transporter	solute-binding	protein	EUR_01830	(Cockburn	et	al.,	2015b).	Here	we	present	a	structural	
and	functional	characterization	of	the	cell	surface	amylase	EUR_21100,	which	we	have	renamed	
Amy13K,	and	demonstrate	empirically	that	Amy13K	contains	five	discrete	starch-binding	CBMs	that	
establish	two	new	CBM	families	and	are	critical	for	starch	processing.	These	new	CBM	families	exhibit	
an	extremely	narrow	taxonomic	distribution,	suggesting	that	they	are	highly	adapted	to	the	niche	of	E.	
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rectale	in	the	human	gut.	These	CBMs	effectively	target	corn	starch,	including	high	amylose	corn	starch,	
but	bind	poorly	to	potato	starch,	explaining	the	weak	activity	of	the	enzyme	against	this	substrate	and	
why	the	organism	cannot	grow	on	resistant	potato	starch.				
Results	
Amy13K	harbors	CBMs	that	define	novel	families	
We	previously	reported	that	E.	rectale	Amy13K	(EUR_21100)	was	likely	comprised	of	five	CBMs	at	its	N-
terminus	based	upon	weak	sequence	homology	to	the	starch-binding	families	CBM26	(BLAST	E-value	
2e-5)	and	CBM41	(BLAST	E-value	1e-5	–	5e-7)	(Cockburn	et	al.,	2015b).	The	biochemical	and	structural	
data	presented	here	supports	that	there	are	five	CBMs,	labeled	as	CBMa-e,	and	two	warrant	
classification	into	new	CBM	families	(Fig	1)	within	the	Carbohydrate	Active	enZymes	database:	
www.cazy.org	(Lombard	et	al.,	2014).	CBMb	and	CBMc	showed	similarity	to	several	CBM26	modules	
(Fig	S1)	allowing	them	to	be	placed	in	this	family.	Similarly	CBMd	showed	relatedness	to	several	CBMs	
classified	as	CBM41	and	thus	was	assigned	to	that	family	(Fig	S2).	CBMa	and	CBMe	did	not	show	
similarity	to	known	CBM	families	or	to	each	other.	A	BLAST	search	was	then	conducted	against	full	
length	proteins	in	CAZy	to	identify	similar	domains.	CBMa	and	its	homologs	(Fig	S3)	were	classified	in	a	
new	CBM	family	called	CBMxy	(final	numbering	given	at	proof	stage),	while	CBMe	and	its	homologs	
define	family	CBMyz	(Fig	S4)	(final	numbering	given	at	proof	stage).		
The	sequences	of	CBMb	and	CBMc	identify	them	as	members	of	the	CBM26	family	and	their	structures	
presented	here	(later	in	Fig	3)	point	to	their	structural	relationship	to	members	of	this	family	as	well.	
The	CBM26	domains	are	typically	associated	with	α-amylases,	including	enzymes	from	bacteria	related	
to	E.	rectale	(Ramsay	et	al.,	2006).	According	to	Pfam	(pfam.xfam.org)	CBM26s	occur	in	tandem	repeats	
approximately	one	third	of	the	time.	Conversely,	CBMd	can	be	placed	within	the	CBM41	family,	though	
it	is	a	somewhat	distant	relative,	exhibiting	only	a	28%	sequence	identity	with	its	closest	relative	within	
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the	family.	Despite	this,	it	can	be	placed	within	subfamily	5	of	this	group,	which	includes	the	T.	
maritima	PulA	CBM41,	its	closest	structural	homologue	(Janecek	et	al.,	2017).	This	group	is	
characterized	by	the	pattern	of	its	aromatic	residues	with	W-X-W-~30aa-W,	with	the	first	tryptophan	
acting	as	a	hydrogen-bonding	residue,	while	the	second	and	third	form	the	aromatic	binding	platform	
for	starch	recognition.	These	residues	are	W416,	W418	and	W469	in	CBMd.	While	the	51	amino	acid	
distance	between	the	second	and	third	tryptophan	is	larger	than	the	typical	distance	seen	in	this	
subfamily,	there	is	some	variability	in	this	distance	(Janecek	et	al.,	2017).	This	atypical	distance	and	the	
overall	low	sequence	identity	with	its	fellow	family	members	may	be	due	to	the	fact	that	there	are	no	
prior	examples	of	CBM41s	from	organisms	closely	related	to	E.	rectale,	as	the	CBMs	in	this	family	
cluster	along	taxonomic	lines	(Janecek	et	al.,	2017).	Intriguingly	Pfam	indicates	that	CBM41s	occur	as	
tandem	pairs	a	slight	majority	of	the	time.	This	suggests	that	the	new	CBMxy	family	may	be	
evolutionarily	related	to	CBM41	and	has	diverged	over	time.	In	general	the	CBM41	family	of	binding	
domains	is	typically	associated	with	pullulanases,	i.e.	α-1,6	specific	enzymes.	The	catalytic	domain	of	
Amy13K	is	related	to	the	pullulanase	subfamilies	(GH13_12	and	GH13_14)	(Cockburn	et	al.,	2015b,	
Møller	et	al.,	2016),	though	the	enzyme	itself	is	an	α-amylase,	i.e.	α-1,4	specific	(Cockburn	et	al.,	2015b)	
and	assigned	to	subfamily	GH13_41.	Interestingly	the	GH13_41	domains	are	typically	found	in	
multidomain	proteins	in	conjunction	with	one	of	the	pullulanase	families	mentioned	above	(Møller	et	
al.,	2016)	suggesting	GH13_41	may	have	arisen	from	duplication	of	the	pullulanase	domains	followed	
by	further	evolution	or	vice	versa.		
Intriguingly	CBMa	and	CBMe	each	represent	novel,	previously	uncharacterized	CBM	families.	Their	
narrow	distribution	among	similar	gut	bacteria	within	the	Lachnospiraceae	points	to	the	highly	
specialized	nature	of	these	binding	modules.	Having	a	single	large	enzyme	with	a	variety	of	adapted	
starch	specific	CBMs	seems	to	be	employed	by	a	number	of	members	of	the	Lachnospiraceae.	Both	
Roseburia	inulinovorans	and	Butyrivibrio	fibrosolvens	possess	a	large	cell-associated	amylase	(Ramsay	
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et	al.,	2006).	The	catalytic	domain	of	Amy13K	and	R.	inulinovorans	Amy13a	both	belong	to	the	
GH13_41	subfamily	and	the	Amy13K_CBMa	has	a	strong	resemblance	to	the	N-terminal	R1	and	R2	
domain	of	Amy13a	and	together	are	part	of	the	newly	defined	family	CBMxy	(Fig	S3).	Additionally,	the	
previously	described	PUD	domain	(now	CBM41)	of	Amy13a,	is	similar	to	Amy13K_CBMd	and	both	also	
have	CBMs	that	are	part	of	the	new	CBMyz	family	(Fig	S4).	While	both	enzymes	have	large	N-terminal	
regions	upstream	of	their	catalytic	domains,	these	regions	have	little	sequence	similarity	other	than	the	
domains	already	mentioned.	In	contrast	the	B.	fibrosolvens	protein	has	an	entirely	different	domain	
organization	with	the	catalytic	domain	at	the	C-terminus,	followed	by	a	pair	of	CBM26	domains.	Thus	
members	of	this	family	of	bacteria	seem	to	have	diverged	over	time	with	regards	to	their	machinery	for	
starch	digestion,	perhaps	as	part	of	their	segregation	into	subtly	different	niches	within	the	gut.	
Crystal	structures	of	Amy13K	CBMd	(CBM41)	and	CBMbc	(CBM26)	
We	performed	extensive	crystallization	trials	on	all	CBM	constructs,	yet	were	only	successful	in	
obtaining	crystals	and	structures	of	three	domains:	CBMd	and	CBMbc.	Crystallization	trials	of	CBMde	
yielded	crystals	of	CBMd	alone	after	several	months,	suggesting	flexibility	between	the	domains	
inhibited	crystal	formation	until	proteolysis	occurred.	Attempts	to	produce	crystals	of	CBMe	alone	were	
unsuccessful.	The	structure	of	Amy13K_CBMd	was	solved	to	a	resolution	of	2.20	Å	(Rwork	=	23.4%,	Rfree	=	
25.7%)	revealing	a	β-sandwich	fold	like	other	CBM41	structures	(Fig	2A).	A	search	of	the	DALI	server	
suggests	that	the	closest	structural	relatives	of	CBMd	are	the	CBM41	domain	of	Thermotoga	maritima	
pullulanase	PulA	(PDB	2J73,	Z-score	=	10.6)	(Lammerts	van	Bueren	&	Boraston,	2007),	which	also	shares	
22%	sequence	identity,	and	the	CBM41	domains	of	Streptococcus	pneumoniae	alkaline	amylopullanase	
SpuA	(PDB	2J44,	Z-score	=	9.3)	(Lammerts	Van	Bueren	et	al.,	2004b).		Overall	the	secondary	structure	
elements	of	CBMd	align	well	with	those	of	the	CBM41s	from	PulA	and	SpuA	with	the	major	differences	
confined	to	loop	regions.	An	overlay	of	the	structure	of	CBM41d	with	that	of	CBM41	in	PulA	with	
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bound	maltotriose	(PDB	2J73)	identified	the	putative	starch-binding	site	by	conservation	with	similar	
starch-binding	residues	in	PulA	(Fig	2B).	In	PulA,	the	aromatic	platform	comprised	of	W29	and	W73	
overlays	well	with	residues	W418	and	W469	of	CBMd.	Likewise	in	CBMd,	additional	hydrogen-bonding	
to	the	hydroxyl	oxygens	of	adjacent	glucose	residues	may	be	supported	by	W416,	K460,	and	D477,	
which	are	present	as	W27,	K76	and	D81	in	PulA.		As	seen	in	many	starch-binding	proteins,	the	aromatic	
binding	platform	forms	the	classic	convex	angle	that	matches	the	helical	pitch	of	amylose	and	
amylopectin	chains	(Imberty	et	al.,	1991).	This	orientation	is	seen	in	diverse	starch-binding	proteins	
ranging	from	dedicated	starch-binding	proteins	like	SusD	(Koropatkin	et	al.,	2008),	to	CBMs	(Boraston	
et	al.,	2006)	and	surface	binding	sites	on	amylolytic	enzymes	(Cockburn	&	Svensson,	2016).		
We	determined	the	crystal	structure	of	CBMbc	with	maltoheptaose	(2.01	Å,	Rwork	=	18.9%,	Rfree	=	20.0%)	
and	without	(2.10	Å,	Rwork	=	20.8%,	Rfree	=	23.2%)(Fig	3A).		In	the	substrate	bound	structure,	the	
maltoheptaose	molecule	bound	to	CBMb	spans	across	adjacent	asymmetric	units	and	likely	facilitated	
crystallization.	The	structures	of	the	free	and	maltoheptaose	bound	proteins	overlay	well	with	an	RMSD	
<0.4	Å	for	all	Cα	atoms,	and	thus	no	structural	change	occurs	upon	ligand	binding.	Both	CBMb	and	
CBMc	display	bound	maltoheptaose	with	some	minor	differences.	Both	CBMs	possess	a	pair	of	
aromatic	residues	at	the	center	of	the	binding	interface,	however	in	CBMb	these	are	a	tyrosine	(Y198)	
and	a	tryptophan	(W208),	while	in	CBMc	they	are	a	pair	of	tryptophans	(W299,	W314)	(Fig	3B,C).	
Comparing	the	CBMs,	the	phenol	ring	of	Y198	overlays	with	the	indole	ring	of	W299,	while	there	is	a	
2.4	Å	separation	between	the	relative	positions	of	W208	and	W314.	In	addition	to	the	aromatic	binding	
platform	there	are	several	conserved	hydrogen	bonds	between	the	two	CBMs.	The	Y196	and	Y297	
hydroxyl	groups	form	hydrogen	bonds	with	the	O6	of	the	glucose	stacking	on	Y198	and	W299,	
respectively,	while	Q247	and	Q352,	form	hydrogen	bonds	with	both	the	O2	and	O3	of	the	glucose	
stacked	on	W208	and	W314,	respectively.	In	CBMc	N355	forms	a	hydrogen	bond	with	the	O3	of	the	
glucose	stacked	on	W299,	however,	the	equivalent	residue	in	CBMb,	D250,	has	a	water-mediated	
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contact	with	the	O2	of	the	glucose	stacked	on	Y198.	A	loop	spanning	from	K199	to	P204	in	chain	A	of	
CBMb	diverges	in	position	from	the	equivalent	loop	in	CBMc	(A301-A308)	and	forms	contacts	with	the	
glucose	residues	of	the	maltoheptaose	molecule	as	it	spans	into	the	neighboring	asymmetric	unit	into	
the	binding	site	of	CBMc.	This	places	E200	and	N202	of	CBMb	chain	A	in	hydrogen	bonding	position	
with	the	maltoheptaose	molecule	as	it	extends	out	of	the	CBMb	binding	site,	potentially	expanding	the	
CBMb	binding	site	(Fig	3B,	Fig	S5).	The	equivalent	loop	in	CBMc	from	A301-A308	is	composed	of	smaller	
sidechains,	packing	into	the	body	of	the	CBM	and	does	not	appear	to	be	capable	of	making	additional	
contacts	to	a	longer	sugar.		
Like	CBMd,	both	CBMb	and	CBMc	exhibit	the	typical	β-sandwich	fold	seen	in	many	CBMs	(Fig	3A).	DALI	
searches	reveal	that	the	closest	structural	matches	for	CBMb/c	are	the	CBM25	(2C3X,	Z-score	=	
11.7/10.5)	and	CBM26	(2C3H,	Z-score	=	10.7/10.1)	from	Bacillus	halodurans	α-amylase	(Boraston	et	al.,	
2006)	along	with	the	CBM25	from	the	Paenibacillus	polymyxa	β/α-amylase	(PDB	2LAA,	Z-score	=	
10.7/10.1).	Somewhat	weaker	matches	are	found	to	the	CBM41	family	of	domains,	despite	our	
previous	suggestion	that	CBMbc	might	be	members	of	this	family	(Cockburn	et	al.,	2015b).	An	overlay	
with	the	CBM26	from	B.	halodurans	(2C3H)	shows	a	high	degree	of	overlap	between	the	aromatic	
platform	residues	from	both	CBMb	and	c,	as	well	as	some	of	the	hydrogen	bonding	residues	of	these	
CBMs.	Of	note,	Y196/Y297	from	CBMb/c	with	Y23	from	B.	halodurans	CBM26	as	well	as	Q247/352	from	
CBMb/c	with	Q71	from	B.	halodurans	CBM26	(Fig	3D,E)	are	superimposable.	Thus	it	appears	that	CBMb	
and	CBMc	are	most	structurally	homologous	to	CBM26,	supporting	their	placement	within	this	family.	
Amy13K	CBMs	bind	soluble	starch	and	oligosaccharides	
A	total	of	six	recombinant	protein	constructs	were	used	in	this	study	to	test	the	ability	of	the	Amy13K	
CBMs	to	bind	to	starch	(Fig	1).	The	CBMs	were	expressed	independently	(e.g.	CBMa)	or	in	combination	
(e.g.	CBMa-e)	to	examine	how	they	might	synergize	to	enhance	starch-binding.		Both	affinity	
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electrophoresis	and	isothermal	titration	calorimetry	(ITC)	were	used	to	determine	the	binding	of	the	
constructs	to	polymers	and	smaller	maltooligosaccharides.		In	affinity	electrophoresis	binding	is	
monitored	via	migration	of	the	protein	through	an	acrylamide	gel	in	the	presence	or	absence	of	ligand	
and	slower	migration	occurs	as	the	protein	interacts	with	polysaccharide	(Cockburn	et	al.,	2017,	Abbott	
&	Boraston,	2012).	By	affinity	electrophoresis,	all	of	the	CBM	constructs	except	the	CBMe	construct	
displayed	binding	to	both	amylopectin	and	pullulan	(Fig	4).		While	amylopectin	is	one	of	the	two	
components	of	starch	along	with	amylose,	pullulan	is	a	linear	fungal	cell	wall	polysaccharide	composed	
of	α-1,6	linked	maltotriose	residues.	Like	amylopectin,	pullulan	contains	both	α-1,4	and	α-1,6	linkages,	
however,	it	is	linear	rather	than	branched	and	has	a	much	greater	frequency	of	α-1,6	bonds,	occurring	
every	three	linkages	(Prajapati	et	al.,	2013).	Thus	it	serves	as	a	model	substrate	for	de-branching	
enzymes	and	can	be	useful	for	determining	the	tolerance	for	and	importance	of	α-1,6	linkages	for	
binding	(Cockburn	et	al.,	2015a).	While	CBMa	and	CBMbc	display	slower	migration	in	the	presence	of	
amylopectin,	which	has	longer	regions	of	α1,4-linked	glucan,	the	CBMde	construct	is	slowed	much	
more	by	the	presence	of	pullulan.		Enhanced	binding	to	pullulan	could	be	driven	by	specific	interactions	
with	CBMd	or	due	to	enhanced	avidity	from	the	tandem	CBM	construct.	Indeed,	longer	constructs	such	
as	CBMb-e	and	CBMa-e	also	displayed	some	enhanced	binding	to	pullulan	over	amylopectin,	either	due	
to	the	presence	of	CBMde	or	by	avidity.	From	the	crystal	structure	of	CBMd	without	substrate,	it	is	
difficult	to	speculate	how	this	CBM	may	specifically	accommodate	α1,6	linkages,	however,	it	may	be	
the	influence	of	the	α1,6	bond	on	the	surrounding	structure	that	is	recognized.	The	α1,6	bond	
introduces	considerable	structural	flexibility	relative	to	α1,4	bonds,	resulting	in	pullulan	behaving	as	a	
random	coil	in	solution	compared	to	the	helices	formed	by	amylose	(Dais	et	al.,	2001).	In	starch,	the	
branch	points	cause	the	creation	of	amorphous	layers	that	alternate	with	the	longer	linear	regions	that	
make	up	the	crystalline	layers	(Damager	et	al.,	2010).	Thus	it	takes	3-6	glucose	residues	after	an	α1,6	
linkage	before	regular	helices	begin	to	form	(Motawia	et	al.,	2005)	and	it	is	possible	that	CBMd	and	or	
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CBMe	preferentially	recognize	these	less	ordered	regions.	In	total,	these	data	suggest	some	differences	
in	the	relative	affinity	and	tolerance	of	the	various	CBMs	towards	α1,6	branch	points	in	starch,	and	
likely	help	the	enzyme	recognize	a	variety	of	starch	particles	in	the	gut	environment.			As	expected,	
none	of	the	CBMs	demonstrated	binding	to	dextran	(data	not	shown),	an	all	α-1,6	polymer	of	glucose	
on	which	Amy13K	lacks	activity.	
ITC	was	also	utilized	to	determine	the	affinity	of	the	CBMs	to	glycogen,	maltoheptaose	and	β-
cyclodextrin.	Glycogen	is	a	starch-like	storage	molecule	in	many	animals	and	bacteria,	and	it	is	
structurally	similar	to	amylopectin	with	an	increased	α1,6-branch	frequency	making	it	much	more	
soluble	and	thus	easily	used	in	ITC.	Maltoheptaose	represents	a	stretch	of	α-1,4	linked	glucose	with	
flexible	geometry	and	typically	longer	than	the	binding	surface	of	CBMs,	while	β-cyclodextrin	is	
identical	in	composition	to	maltoheptaose	but	circular,	with	a	curvature	matching	that	seen	in	amylose	
(Imberty	et	al.,	1991).	All	of	the	CBM	constructs	tested	exhibited	binding	to	each	of	these	ligands	(Table	
2),	with	varying	affinity.	For	the	oligosaccharides	most	constructs	displayed	similar	affinity	for	
maltoheptaose	and	β-cyclodextrin	with	Kd	in	the	10-3	to	10-4	M	range,	somewhat	weaker	than	has	
previously	been	observed	in	CBM26	at	10-5	M	(Boraston	et	al.,	2006)	and	CBM41	at	10-6	M	(Lammerts	
van	Bueren	et	al.,	2004a),	though	this	latter	was	derived	from	a	thermophile	which	may	explain	the	
tighter	binding	at	room	temperature.	Interestingly	the	CBMde	construct	had	a	Kd	for	maltoheptaose	
approximately	an	order	of	magnitude	lower	than	that	for	β-cyclodextrin.	This	is	consistent	with	
increased	affinity	for	binding	near	branch	points	where	the	helical	structure	of	the	starch	is	disrupted,	
and	in	line	with	our	affinity	electrophoresis	data.	The	longer	constructs,	CBMb-e	and	CBMa-e	each	
displayed	higher	affinity	for	the	oligosaccharides	than	the	smaller	constructs.	As	we	do	not	expect	
cooperativity	in	the	binding	of	these	substrates	nor	do	we	expect	the	substrates	to	span	multiple	CBMs,	
we	speculate	that	improved	structural	stability	in	the	larger	constructs	may	be	responsible	for	this	
enhanced	affinity.	With	glycogen,	the	individual	constructs	CBMa	and	CBMe	display	binding	with	Kd	
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~10-4	M,	and	this	is	enhanced	an	order	of	magnitude	(Kd	~10-5	M)	when	two	CBMs	such	CBMbc	or	
CBMde	are	expressed	in	tandem.	Glycogen	binding	is	further	enhanced	an	additional	two	orders	of	
magnitude	(Kd	~10-7	M)	when	four	or	five	CBMs	are	expressed	in	tandem	as	in	CBMa-e	and	CBMb-e,	
demonstrating	that	there	is	a	significant	avidity	effect	from	having	multiple	CBMs.	When	considering	
the	binding	of	CBMs	to	a	polysaccharide	it	is	not	just	the	affinity,	but	also	the	frequency	of	binding	sites	
that	is	important.	Not	surprisingly	the	single	CBM	constructs	have	a	relatively	high	frequency	of	binding	
sites	in	glycogen	(Table	2,	values	in	parentheses)	with	CBMa	displaying	a	binding	site	frequency	of	2.3	
mM/%	glycogen,	while	CBMe	is	somewhat	lower	at	0.8	mM/%		glycogen.	Interestingly	the	dual	CBM	
constructs	diverge	significantly	in	this	regard	with	CBMbc	displaying	a	binding	site	frequency	of	only	
0.05	mM/%	glycogen,	while	CBMde	is	at	2.4	mM/%	glycogen,	despite	the	similar	affinities	of	these	two	
constructs	for	glycogen.	This	higher	frequency	for	binding	sites	for	CBMde	may	suggest	that	these	
CBMs	have	a	greater	tolerance	for	the	frequent	α-1,6	branch	points	in	glycogen	in	line	with	its	greater	
affinity	for	pullulan	in	the	AE	gels	(Fig	4).	The	longer	constructs	CBMb-e	and	CBMa-e	seem	to	be	limited	
by	the	CBMbc	binding	restrictions	as	they	display	similar	binding	site	frequencies	at	0.06	mM/%	
glycogen	and	0.1	mM/%	glycogen,	respectively,	though	with	significantly	better	affinities.	Thus	the	
combination	of	these	CBMs	provides	high	affinity	binding,	but	perhaps	at	the	cost	of	less	frequent	
binding	sites.	Furthermore	this	appears	to	be	driven	not	just	by	avidity	effects	and	size	of	the	construct,	
but	also	by	differing	binding	specificities.									
Binding	of	CBMs	to	granular	starch	
In	complement	to	binding	studies	with	soluble	substrates,	the	ability	to	interact	with	granular	starch,	
which	represents	some	of	the	starch	that	would	be	expected	to	traverse	the	distal	gut,	was	
investigated.		In	these	adsorption	assays,	proteins	and	starch	were	incubated	followed	by	
centrifugation	to	determine	the	remaining	concentration	of	unbound	protein.	Binding	of	the	CBM	
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constructs	to	standard	cornstarch,	whole	grain	corn	starch,	a	high	amylose	corn	starch	(HiMaize	260),	
potato	starch,	and	the	chemically	modified	resistant	starch	Fibersym	was	tested	(Table	3).	No	binding	
was	detected	for	whole	grain	corn	starch	(data	not	shown)	likely	because	the	starch	itself	is	inaccessible	
due	to	the	presence	of	the	bran,	making	it	a	type-1	resistant	starch	(Birt	et	al.,	2013).	It	has	not	been	
tested	if	whole	grain	starch	serves	as	a	growth	substrate	for	E.	rectale,	but	this	result	suggests	it	is	
unlikely.	Significant	binding	towards	Fibersym	was	only	evident	for	the	CBMa-e,	and	CBMb-e	
constructs,	suggesting	that	no	single	CBM	domain	drives	affinity,	rather	avidity	from	multiple	domains	
is	required.	With	regular	corn	starch,	similar	binding	was	observed	among	the	CBMa	and	CBMde	
constructs,	while	CBMbc	displays	~3-fold	lower	affinity.	The	pairing	of	these	CBMs	together	in	the	
longer	constructs	CBMa-e	and	CBMb-e	did	not	significantly	enhance	binding,	suggesting	avidity	is	not	as	
important	for	access	to	corn	starch.	However,	for	the	high-amylose	starch	HiMaize260,	the	longer	
CBMa-e	and	CBMb-e	constructs	displayed	3-10-fold	enhanced	affinity	over	the	smaller	constructs.	
Surprisingly,	the	CBMa-e	construct	on	average	had	lower	affinity	than	the	construct	lacking	only	CBMa,	
despite	the	fact	that	CBMa	binds	HiMaize	with	similar	affinity	to	the	CBMbc	and	CBMde	constructs.	
Thus	Amy13K	CBMs	seem	to	recognize	high-amylose	and	mixed	amylopectin/amylose	corn	starches	
with	similar	affinities.	This	was	consistent	across	most	of	the	CBM	constructs	tested,	suggesting	that	
these	two	forms	of	corn	starch	present	similar	binding	surfaces	to	Amy13K.		
Interestingly,	the	CBMs	of	Amy13K	do	not	appreciably	bind	potato	starch,	with	only	slight	binding	
observed	for	the	largest	CBM	construct,	and	binding	was	not	saturable.	Relatively	few	studies	have	
examined	the	difference	in	binding	between	corn	starch	and	potato	starch	for	amylolytic	CBMs,	though	
both	the	pig	pancreatic	amylase	(Warren	et	al.,	2011)	and	the	barley	α-amylase	AMY1	(Cockburn	et	al.,	
2015a)	have	surface	binding	sites	that	seem	to	preferentially	bind	corn	starch	over	potato	starch.	One	
interesting	study	found	that	for	the	A.	niger	CBM20	the	affinity	for	potato	starch	and	corn	starch	
binding	sites	seemed	to	be	the	same,	but	there	were	far	fewer	of	the	binding	sites	available	on	the	
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potato	starch,	resulting	in	a	much	lower	apparent	affinity	(Paldi	et	al.,	2003).	One	point	to	note	is	that	
the	approximately	7-fold	difference	in	CBM20	binding	sites	in	this	study	is	significantly	larger	than	the	
~3-fold	difference	in	specific	surface	area	between	these	two	starch	types	(Warren	et	al.,	2011).	This	
indicates	that	it	is	not	just	the	size	of	the	surface	available	for	binding	that	differs,	but	also	the	
frequency	of	structural	binding	motifs.	Binding	to	the	surface	of	starch	granules	is	an	important	barrier	
to	enzyme	action	as	the	granule	interiors	seem	to	be	readily	attacked	(Gallant	et	al.,	1992),	even	by	
enzymes	lacking	CBMs	or	surface	binding	sites	(Cockburn	et	al.,	2015a).	Removal	of	the	CBM(s)	of	the	
Microbacterium	aurum	α-amylase	MaAmyA	removed	the	ability	of	the	enzyme	to	form	pores	in	starch	
granules	(Valk	et	al.,	2015).	Interestingly,	it	was	discovered	that	this	enzyme	possesses	a	novel	type	of	
CBM,	which	was	assigned	to	the	new	CBM74	family	(Valk	et	al.,	2016).	This	CBM	is	of	particular	interest	
as	it	displays	a	10-fold	better	affinity	for	potato	starch	compared	to	corn	starch	and	is	enriched	in	gut	
bacteria,	particularly	resistant	starch	degraders	such	as	a	variety	of	Bifidobacterium	species	and	R.	
bromii.	Thus	acquiring	novel	binding	functionalities	may	be	a	key	adaptation	of	potato	starch-degrading	
organisms.				
Activity	of	Amy13K	and	CBM	truncation	mutants	
To	probe	the	role	of	these	CBMs	on	enzyme	activity,	the	activity	of	the	full-length	(WT)	enzyme	was	
compared	to	that	of	truncation	mutants	lacking	one,	three	or	all	five	of	the	identified	CBMs	(Fig	1).	In	
preliminary	tests,	constructs	lacking	three	or	all	five	CBMs	displayed	greatly	reduced	activity	such	that	
substrate	saturation	could	not	be	attained,	even	when	pushed	to	the	maximum	feasible	levels.		In	
addition,	none	of	the	enzyme	constructs	exhibited	saturation	kinetics	for	the	potato	starch.	Therefore	
we	compared	the	catalytic	efficiency	(kcat/KM)	of	these	constructs	to	focus	on	the	role	of	these	CBMs	on	
starch	hydrolysis.		
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To	examine	if	removal	of	the	CBMs	affected	activity	of	the	enzyme	overall,	we	measured	the	catalytic	
efficiency	of	the	WT	and	ΔCBMa-e	on	maltoheptaose,	as	hydrolysis	of	this	small	substrate	would	not	be	
subject	to	an	avidity	affect	via	the	CBMs.	The	catalytic	efficiency	of	the	WT	and	ΔCBMa-e	on	
maltoheptaose	are	2.8	x104	±	1.9	x104	s-1M-1	and	1.2	x104	±	8.6	x103	s-1M-1	respectively,	suggesting	that	
these	truncated	constructs	have	a	slightly	lower	inherent	activity	as	it	is	unclear	how	the	CBMs	could	
contribute	to	activity	on	a	small	substrate.	However,	with	soluble	starch	amylopectin,	the	same	2-3-fold	
decrease	in	catalytic	efficiency	between	the	full-length	enzyme	and	the	constructs	lacking	various	CBMs	
was	observed,	suggesting	the	CBMs	are	not	required	to	enhance	access	to	this	substrate	(Table	4).	This	
is	despite	the	efficient	binding	of	these	CBMs	to	the	similar	substrate	(Table	2),	suggesting	a	high	
affinity	of	the	enzyme	active	site	for	amylopectin	that	is	not	further	enhanced	by	the	CBMs.	
Intriguingly,	activity	levels	were	similar	for	each	construct	towards	both	regular	and	high-amylose	corn	
starch	granules.	This	is	in	line	with	the	binding	assays	for	these	substrates,	and	may	suggest	that	the	
initial	surface	presented	to	the	enzyme	by	these	substrates	is	similar.	For	both	regular	and	HiMaize	
corn	starch	there	is	a	significantly	higher	dependence	on	the	CBMs	with	the	activity	decreasing	by	an	
order	of	magnitude	as	the	CBMs	are	removed.	In	contrast	the	potato	starch,	which	has	a	low	
dependence	on	the	CBMs,	displayed	an	approximately	3-fold	decrease	in	activity	for	the	ΔCBMa-e	
enzyme	compared	to	the	WT	enzyme.	Most	strikingly	the	enzymes	lacking	3	or	all	5	of	the	CBMs	show	
similar	activity	towards	the	three	insoluble	starches,	while	the	full	length	enzyme	shows	a	much	more	
dramatic	decrease	in	catalytic	efficiency	between	the	corn	starches	and	the	potato	starch.		
Potato	starch	adopts	the	B-type	crystalline	form,	as	opposed	to	the	A-type	form	seen	in	most	corn	and	
wheat	starches	(Imberty	et	al.,	1991).	High	amylose	corn	starch	such	as	the	HiMaize	260	used	in	this	
study	also	adopts	the	B-type	crystalline	form	and	this	may	explain	its	resistance	to	degradation	(Gallant	
et	al.,	1992).	Interestingly	the	Amy13K	CBMs	bind	similarly	to	both	regular	corn	starch	and	HiMaize260	
and	the	enzyme	exhibits	similar	activity	towards	the	two	substrates.	This	indicates	that	surface	binding	
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does	not	represent	the	barrier	to	efficient	degradation	(and	hence	growth)	in	this	case	as	it	does	with	
potato	starch.	It	should	be	noted	that	the	activities	measured	in	this	study	only	represent	the	initial	
stages	of	degradation	that	occurs	on	the	granule	surface.	It	is	possible	that	the	total	amount	of	starch	
susceptible	to	degradation	by	Amy13K	is	much	smaller	for	HiMaize260	compared	to	regular	corn	
starch,	once	the	granule	surface	has	been	degraded.		
One	final	construct	was	tested	where	all	the	identified	CBMs	as	well	as	an	additional	~200	amino	acids	
that	occur	between	the	CBMs	and	the	predicted	start	of	the	GH13	catalytic	domain,	labeled	as	the	
unknown	region	in	Fig	1,	were	removed.	While	we	were	able	to	obtain	large	amounts	of	this	
recombinant	protein	in	a	soluble	form	during	expression	in	E.	coli,	it	had	no	detectable	activity,	even	
towards	soluble	substrates	and	oligosaccharides.	Secondary	structure	predictions	(JPred4,	
http://www.compbio.dundee.ac.uk/jpred/)	(Drozdetskiy	et	al.,	2015)	do	not	indicate	β-strand	rich	
regions	as	are	typically	found	in	CBMs	and	there	are	no	domains	with	ascribed	function	that	match	this	
sequence.	However,	this	region	clearly	plays	an	important	structural	role	in	Amy13K,	perhaps	directly	
impacting	the	active	site.		
Discussion	
Importance	of	CBMs	for	activity	
It	has	been	demonstrated	that	CBMs	are	important	for	targeting	substrates	in	complex	environments	
such	as	the	plant	cell	wall	(Hervé	et	al.,	2010)	and	undoubtedly	the	breakdown	of	starch	in	the	gut	
provides	similar	challenges.	During	in	vitro	studies	the	removal	of	a	starch	binding	CBM20	abolished	
activity	of	the	Aspergillus	niger	glucoamylase	towards	granular	starch	(Svensson	et	al.,	1982).	
Conversely,	recombinantly	fusing	this	CBM20	to	the	barley	α-amylase	AMY1	increased	its	activity	
towards	granular	starch	6-fold	(Juge	et	al.,	2006).	This	is	despite	the	fact	that	AMY1,	while	lacking	a	
CBM,	has	a	pair	of	surface	binding	sites	on	its	catalytic	module,	which	have	been	shown	to	be	
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important	for	its	activity	(Cockburn	et	al.,	2015a,	Nielsen	et	al.,	2009,	Nielsen	et	al.,	2012).	In	Amy13K	
we	have	identified	five	CBMs	that	provide	the	enzyme	with	affinity	for	starch	granules.	Removal	of	
these	CBMs	has	little	impact	on	the	activity	of	the	enzyme	towards	maltoheptaose	or	soluble	
amylopectin,	but	has	a	more	dramatic	effect	on	the	activity	towards	cornstarch	granules.	Notably	this	
difference	disappears	when	examining	activity	towards	potato	starch,	for	which	the	CBMs	have	
apparently	less	affinity.	The	protein	lacking	all	five	CBMs	displays	little	discrimination	between	the	
three	types	of	insoluble	starches	tested,	suggesting	that	the	CBMs	account	for	the	differences	in	
activity	against	these	substrates.	The	lower	activity	and	lack	of	dependence	on	the	CBMs	for	potato	
starch	corresponds	to	the	lack	of	binding	seen	for	the	isolated	CBMs.		
Implications	for	relationships	with	other	gut	microorganisms	
Resistant	starch	represents	an	important	substrate	for	the	gut	microbiota,	while	non-resistant	starch	is	
processed	in	the	small	intestine	and	thus	does	not	reach	the	microbial	populations	of	the	large	
intestine.	Potato	and	high	amylose	corn	starch	consist	of	about	40-80%	resistant	starch	(depending	on	
the	specific	type	and	method	of	measurement	used)	(McCleary	&	Monaghan,	2002)	and	thus	a	large	
proportion	of	these	starches	reach	the	colon.	E.	rectale	alone	is	unable	to	grow	on	resistant	starches,	
but	grows	well	in	co-culture	with	resistant	starch	degraders	such	as	Ruminococcus	bromii	(Ze	et	al.,	
2012).	Our	results	suggest	that	for	potato	starch	it	is	the	lack	of	efficient	targeting	by	the	CBMs	of	
Amy13K	that	underpins	the	molecular	basis	for	E.	rectale’s	inability	to	grow	on	this	substrate.	This	
inefficient	targeting	seems	to	be	entirely	due	to	the	granular	structure	of	potato	starch	as	purified	and	
autoclaved	potato	amylopectin	readily	supports	growth	of	E.	rectale	(Desai	et	al.,	2016)	and	is	
efficiently	bound	by	the	Amy13K	CBMs	(Fig	4).			
Despite	its	limited	ability	to	grow	on	resistant	starches,	people	who	consume	resistant	starch	often	
have	increased	levels	of	E.	rectale	in	their	large	intestine	(Martínez	et	al.,	2010,	Martínez	et	al.,	2013,	
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Venkataraman	et	al.,	2016).	While	E.	rectale	has	a	suite	of	transporters	specializing	in	the	uptake	of	
starch	breakdown	products	(Cockburn	et	al.,	2015b),	it	would	clearly	be	advantageous	for	the	
organisms	to	localize	to	this	food	source.	E.	rectale	lacks	accessory	starch	binding	proteins	such	as	
those	found	in	the	starch	utilization	system	(Sus)	of	Bacteroides	thetaiotaomicron	(Cameron	et	al.,	
2012,	Foley	et	al.,	2016).	Instead	it	is	possible	that	the	CBMs	of	the	cell	wall	anchored	Amy13K	help	
localize	the	bacteria	to	resistant	starches	such	as	high	amylose	corn	starch.	Indeed	E.	rectale	was	found	
to	colonize	high	amylose	corn	starch	in	an	in	vitro	continuous	flow	system	(Leitch	et	al.,	2007).	E.	
rectale	levels	are	enriched	upon	diet	supplementation	with	potato	starch	(Venkataraman	et	al.,	2016),	
but	given	the	lack	of	binding	to	this	starch	by	the	Amy13K	CBMs	other	means	of	localization	may	be	
needed	or	it	is	possible	that	enough	soluble	material	is	released	by	degraders	to	render	binding	to	
potato	starch	granules	unnecessary.	However,	the	affinity	of	these	CBMs	for	potato	amylopectin	may	
indicate	that	upon	initial	processing	of	potato	starch,	new	binding	sites	are	opened	up	for	binding	by	
Amy13K.	The	Amy13K	CBMs	do	display	weak	binding	to	Fibersym,	a	Type	IV,	chemically	modified	
resistant	starch,	however,	a	study	with	people	consuming	this	starch	did	not	find	elevated	levels	of	E.	
rectale	(Martínez	et	al.,	2010).	It	is	also	currently	unknown	if	this	starch	can	directly	support	E.	rectale	
growth	or	indirectly	through	cross-feeding	with	a	primary	degrader.		
Conclusion	
We	have	identified	and	characterized	the	five	CBMs	of	Amy13K,	which	allow	the	definition	of	two	new	
CBM	families.	These	CBMs	bind	efficiently	to	corn	starch,	including	high	amylose	corn	starch	as	well	as	
amylopectin	and	maltooligosaccharides,	but	display	little	affinity	for	potato	starch.	The	low	affinity	of	
these	CBMs	for	granular	potato	starch	may	be	a	key	factor	in	the	low	activity	of	Amy13K	for	this	
substrate	and	provides	a	molecular	rationale	for	why	this	is	a	poor	growth	substrate	for	E.	rectale.	In	
contrast	it	seems	that	other	factors	are	at	play	in	limiting	the	ability	of	E.	rectale	to	utilize	high	amylose	
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corn	starch	as	the	surface	binding	and	initial	rates	of	degradation	are	similar	to	regular	corn	starch.	It	
could	be	that	following	the	initial	surface	erosion	the	binding	motifs	recognized	by	the	Amy13K	CBMs	
are	eliminated	decreasing	affinity	and	activity	to	that	seen	with	potato	starch.	Indeed,	in	previous	work	
examining	the	ability	of	E.	rectale	to	utilize	corn	starches,	the	bacterium	can	utilize	less	than	20%	of	
high	amylose	corn	starch	when	cultured	with	the	raw	granules	that	have	not	been	heat	treated	(Ze	et	
al.,	2012).		Our	results	presented	here	provide	important	insight	into	the	potential	roles	of	CBMs	in	
determining	substrate	utilization	profiles	in	the	human	gastrointestinal	tract.		
Experimental	procedures	
Reagents	
Primers	used	for	cloning	were	synthesized	by	IDT	DNA	Technologies	and	are	listed	in	Table	S1.	
HiMaize260	starch	and	whole	grain	starch	were	kindly	provided	by	Ingredion	(Bridgewater,	NJ,	USA).	
FiberSym	starch	(MGP	Ingredients)	was	a	gift	from	Jens	Walter	(University	of	Alberta,	Canada).		All	
other	chemicals	were	purchased	from	Sigma	Aldrich,	except	where	noted.	
Cloning,	protein	expression	and	purification	
All	genes	and	gene	fragments	were	amplified	from	E.	rectale	genomic	DNA	using	the	Phusion™	Flash	
polymerase	(Thermo	Fisher	Scientific)	according	to	the	manufacturer’s	instructions	and	all	primer	
sequences	are	listed	in	Table	S1.	All	genetic	constructs	used	in	this	study	were	created	using	the	
Expresso®	T7	Cloning	system	(Lucigen	Inc.)	according	to	the	manufacturer’s	instructions	and	are	listed	
in	Table	S2.	Expression	plasmids	were	transformed	into	E.	coli	Rosetta(DE3)	pLysS	cells,	expressed	and	
purified	as	previously	described	(Cockburn	et	al.,	2015b).	Selenomethionine	substituted	
Amy13K_CBMbc	was	produced	by	first	transforming	the	plasmid	into	E.	coli	Rosetta(DE3)/pLysS	and	
plating	onto	LB	supplemented	with	kanamycin	(50	µg/ml)	and	chloramphenicol	(20	µg/ml).	The	
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bacteria	were	grown	for	16	h	at	37°C	and	then	colonies	were	harvested	from	the	plate	to	inoculate	100	
mL	of	M9	minimal	medium	supplemented	with	the	same	antibiotics.	After	16	h	of	incubation	at	37	°C	
this	starter	culture	was	used	to	inoculate	a	2-liter	baffled	flask	containing	1	liter	of	Molecular	
Dimensions	SelenoMet	premade	medium	supplemented	with	50	ml	of	the	recommended	sterile	
nutrient	mix,	chloramphenicol,	and	kanamycin.	Cultures	were	incubated	at	37°C	until	an	OD600	of	0.45	
was	reached.	At	this	point	the	temperature	was	adjusted	to	20°C	and	each	flask	was	supplemented	
with	100	mg	each	of	L-lysine,	L	-threonine,	and	L-phenylalanine	and	50	mg	each	of	L-leucine,	L-
isoleucine,	L-valine,	and	L-selenomethionine	(Van	Duyne	et	al.,	1993).	After	20	min	of	further	
incubation,	protein	expression	was	induced	by	the	addition	of	0.5	mM	IPTG	and	cultures	were	allowed	
to	grow	for	an	additional	48	h	before	being	harvested.	Cells	were	then	lysed	and	the	protein	purified	as	
previously	described	via	Ni2+	affinity	chromatography	(Cockburn	et	al.,	2015b).		
Crystallization	experiments	
All	proteins	were	subjected	to	a	series	of	96-well	hanging	drop	sparse	matrix	screens	to	identify	
crystallization	conditions.	Selenomethionine-substituted	crystals	of	Amy13k_CBMbc	(54	mg/ml)	were	
obtained	via	hanging	drop	vapor	diffusion	at	room	temperature	against	1.5	M	ammonium	sulfate,	0.1	
M	Bis-Tris	Propane,	pH	7.0	(Hampton	Research	SaltRx).	Native	Amy13K_CBMbc	crystals	were	obtained	
without	(free)	or	with	14mM	maltoheptaose		via	hanging	drop	experiments	against	60%	Tacsimate,	0.1	
M	Bis-Tris	Propane,	pH	7.0	(Hampton	Research	SaltRx),	also	at	room	temperature.	Native	
Amy13K_CBMd	crystals	were	obtained	via	hanging	drop	against	50%	pentaerythritol	propoxylate	(5/4	
PO/OH),	0.1	M	Tris-HCl	pH	8.0	in	the	Molecular	Dimensions	Midas	screen	using	20	mg/mL	protein.	All	
crystals	used	in	this	study	were	cryoprotected	prior	to	freezing	in	liquid	nitrogen	by	quickly	swiping	the	
crystal	through	a	solution	of	80%	mother	liquor	supplemented	with	20%	ethylene	glycol.	X-ray	data	
were	collected	at	the	Life	Sciences	Collaborative	Access	Team	(LSCAT)	beamline	ID-D	of	the	Advanced	
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Photon	Source	at	Argonne	National	Laboratory.	Data	were	integrated	using	iMosFLM	(Battye	et	al.,	
2011)	and	then	indexed	and	scaled	using	the	program	Aimless	(Evans	&	Murshudov,	2013)	from	the	
CCP4	package	(Winn	et	al.,	2011).	For	the	selenomethionine	substituted	Amy13K_CBMbc,	phases	were	
solved	by	single	anomalous	dispersion	(SAD)	using	the	AutoSol	program	of	the	Phenix	package	(Adams	
et	al.,	2010).	This	structure	was	then	used	to	solve	the	native	Amy13K_CBMbc	with	or	without	
maltoheptaose	by	molecular	replacement	using	Phaser-MR	(McCoy	et	al.,	2007)	within	Phenix.	In	the	
substrate	free	structure,	four	molecules	were	found	in	the	asymmetric	unit,	however,	chain	D	exhibited	
higher	mobility	than	the	other	chains	and	not	all	amino	acid	sidechains	from	Y297-I356	could	be	
confidently	fit	to	the	electron	density	and	were	thus	omitted.		The	Amy13K_CBMd	structure	was	solved	
via	sulfur	SAD	after	merging	seven	datasets	from	three	crystals	with	autoPROC	(Vonrhein	et	al.,	2011)	
and	phasing	in	AutoSol.	The	resulting	structure	was	then	used	to	solve	the	structure	from	a	single	
dataset	via	molecular	replacement	with	Phaser-MR.	Structures	were	refined	using	Phenix.refine	
(Afonine	et	al.,	2012).	In	the	maltoheptaose	bound	structure	of	Amy13K_CBMbc	the	conformation	of	
bound	carbohydrates	was	validated	using	Privateer	(Agirre	et	al.,	2015)	from	the	CCP4	package.				
Enzyme	activity	assays	
For	activity	assays	with	polysaccharide	substrates	the	production	of	free	reducing	ends	was	monitored	
using	the	bicinchoninic	acid	(BCA)	method	(Waffenschmidt	&	Jaenicke,	1987)	as	previously	described	
(Cockburn	et	al.,	2015b).	All	reactions	included	10	mM	HEPES	pH	6.5,	with	5	mM	CaCl2	and	0.02%	
Tween80.	All	granular	starch	substrates	were	washed	10x	in	pure	water	prior	to	activity	assays.	For	
activity	towards	amylopectin	Amy13K_WT	(2.2	nM),	ΔCBMa	(2.4	nM),	ΔCBMa-c	(3.0	nM)	or	ΔCBMa-e	
(4.0	nM)	was	incubated	with	six	concentrations	of	potato	amylopectin	(0.003	–	0.5%).	Reactions	were	
monitored	for	30	min.	Initial	velocities	were	calculated	and	fitted	to	a	Michalis-Menten	curve	to	
calculate	kcat	and	KM.	For	activity	towards	corn	starch	Amy13K_WT	(3	nM),	ΔCBMa	(6	nM),	ΔCBMa-c	(15	
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nM)	or	ΔCBMa-e	(26	nM)	were	incubated	with	six	concentrations	of	granular	corn	starch	(0.2	–	10%)	
and	activity	was	monitored	for	135	min.	Initial	velocities	were	plotted	against	substrate	concentration	
and	for	WT	and	ΔCBMa	the	kcat	and	KM	were	derived	through	fitting	to	a	Michalis-Menten	curve.	For	
ΔCBMa-c	and	ΔCBMa-e	it	was	only	possible	to	derive	kcat/KM	from	the	slope	of	the	line.	For	activity	
towards	HiMaize	260	starch,	Amy13K_WT	(4	nM),	ΔCBMa	(8	nM),	ΔCBMa-c	(20	nM)	or	ΔCBMa-e	(40	
nM)	were	incubated	with	six	concentrations	of	granular	HiMaize	260	high	amylose	corn	starch	(0.06	–	
6%)	and	activity	was	monitored	for	135	min.	Initial	velocities	were	plotted	against	substrate	
concentration	and	for	WT	and	ΔCBMa	the	kcat	and	KM	were	derived	through	fitting	to	a	Michalis-Menten	
curve.	For	ΔCBMa-c	and	ΔCBMa-e	it	was	only	possible	to	derive	kcat/KM	from	the	slope	of	the	line.	For	
activity	towards	potato	starch,	Amy13K_WT	(1.1	nM),	ΔCBMa	(1.2	nM),	ΔCBMa-c	(1.5	nM)	or	ΔCBMa-e	
(2.0	nM)	were	incubated	with	six	concentrations	of	granular	potato	starch	(Bob’s	RedMill;	0.5	–	20%).	
Initial	velocities	were	plotted	against	substrate	concentration	and	kcat/KM	was	calculated	from	the	slope	
of	the	line.	Activity	towards	oligosaccharides	was	monitored	via	isothermal	titration	calorimetry.	
Amy13K_WT	(11	nM)	or	ΔCBMa-e	(20	nM)	were	placed	into	the	cell	of	a	standard	volume	Nano	ITC	(TA	
Instruments,	New	Castle,	Delaware).	40	mM	maltoheptaose	was	serially	injected	into	the	cell	while	
stirring	at	350	RPM	at	a	temperature	of	37	°C	(see	Table	S3	for	injection	volumes	and	times).	The	
molecular	enthalpy	of	the	reaction	was	calculated	to	be	4.41	kJ/mol	by	monitoring	the	complete	
conversion	of	10	mM	maltotetraose	to	maltose	by	8	mg/mL	Amy13B,	formerly	EUR_01860	(Cockburn	
et	al.,	2015b)	in	duplicate,	which	agreed	well	with	previous	estimates	(Goldberg	et	al.,	1991).	Catalytic	
parameters	were	determined	using	the	NanoAnalyze	software	(TA	instruments).	
Isothermal	titration	calorimetry	CBM	binding	assays	
CBM	binding	to	maltoheptaose,	β-cyclodextrin	and	glycogen	was	determined	by	isothermal	titration	
calorimetry	(ITC)	using	a	TA	Instruments	low	volume	NanoITC.	For	CBMa,	63	µM	protein	was	titrated	
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with	10	and	13	mM	β-cyclodextrin,	20	mM	maltoheptaose	or	1%	and	2%	glycogen	(MW	~106-107,from	
rabbit	liver).	CBMbc	was	used	at	a	concentration	of	42	µM	and	titrated	with	10	mM	β-cyclodextrin,	10	
and	25	mM	maltoheptaose	or	5%	glycogen.	The	CBMde	construct	was	used	at	a	concentration	of	190	
µM	and	titrated	with	1	mM	and	5	mM	maltoheptaose,	2.5	mM	β-cyclodextrin	or	1%,	1.5%	and	2%	
glycogen.	CBMe	was	measured	at	780	µM	and	titrated	with	10	mM	and	13	mM	β-cyclodextrin,	20	mM	
maltoheptaose	or	5%	and	10%	glycogen.	CBMb-e	was	measured	at	5	µM	and	titrated	with	4	and	5	mM	
β-cyclodextrin,	20	mM	maltoheptaose	or	0.5%	and	1%	glycogen.	CBMa-e	was	measured	at	7.8	µM	and	
titrated	with	2	or	4	mM	β-cyclodextrin,	5	mM	maltoheptaose	or	1%	and	2%	glycogen.	All	data	were	
analyzed	using	the	manufacturer’s	NanoAnalyze	software,	using	a	constant	blank	correction	and	an	
independent	binding	model	unless	otherwise	noted.	To	obtain	Kd	values	it	was	necessary	to	fix	the	
value	of	n	(number	of	binding	sites)	in	these	calculations.	For	maltoheptaose	and	β-cyclodextrin	the	
value	of	n	was	fixed	at	the	number	of	CBMs	in	the	construct	(e.g.	1	for	CBMa,	2	for	CBMbc).	For	
glycogen	the	molar	concentration	of	the	ligand	used	was	empirically	set	such	that	it	produced	a	value	
for	n	of	1	when	fitting	the	curve	to	the	data.	Thus	the	concentration	of	glycogen	used	in	this	calculation	
represents	the	molar	concentration	of	available	binding	sites	on	the	polysaccharide	ligand,	according	to	
the	protocol	of	Abbott	et	al.	(Abbott	&	Boraston,	2012).	The	binding	site	frequency	(mM/%	glycogen)	
for	each	construct	was	calculated	as	the	slope	of	the	concentration	of	binding	sites	over	the	w/v%	of	
glycogen	used.	For	example	the	CBMb-e	construct	was	assayed	for	binding	at	0.5%	and	1%	glycogen.	
The	binding	site	concentration	(the	concentration	found	to	give	n=1	during	curve	fitting)	was	0.022	mM	
and	0.05	mM	respectively.	Calculating	the	slope	(0.05	-	0.022)/(1	-	0.5)	gives	a	binding	site	frequency	of	
0.056	mM/%glycogen	(rounded	to	0.06	in	Table	2).	This	represents	the	concentration	of	binding	sites	
for	a	particular	construct,	i.e.	how	many	copies	can	bind	before	reaching	saturation	for	1%	w/v	
glycogen.	Thus	we	would	expect	lower	numbers	for	larger	constructs	(each	takes	up	more	space)	and	
for	constructs	that	have	a	relatively	infrequently	occurring	binding	motif.				
Page 25 of 40 Molecular Microbiology
This article is protected by copyright. All rights reserved.
A
cc
ep
te
d 
A
rt
ic
le
	 24	
Starch	binding	assays	
Binding	of	isolated	CBMs	to	insoluble	corn	starch,	whole	grain	starch,	HiMaize	260	high	amylose	starch,	
potato	starch	or	Fibersym	chemically	modified	resistant	starch	was	determined	through	protein	
depletion	assays	(Abbott	&	Boraston,	2012).	Prior	to	protein	addition,	the	starch	was	washed	two	times	
with	10	mM	HEPES	pH	6.5,	150	mM	NaCl.	CBMs	(80	µg/mL)	were	then	incubated	with	1-100	mg/mL	
starch	for	10	min	at	room	temp	with	end-over-end	rotation	and	insoluble	material	(including	bound	
protein)	was	removed	by	two	rounds	of	centrifugation	at	20	000	xg.	Protein	concentration	in	the	
supernatant	(unbound)	was	then	determined	by	the	Bradford	assay	(Bio-Rad)	according	to	the	
manufacturer’s	protocol,	using	the	CBM	construct	under	study	as	the	protein	standard.	The	fraction	of	
protein	bound	to	starch	was	then	plotted	against	starch	concentration	to	determine	binding	constants	
using	the	following	formula:	
𝐵 = 𝐵!"#[𝑆]𝐾! + [𝑆]	
Where	B	is	the	fraction	of	protein	bound,	Bmax	is	the	maximum	proportion	of	protein	bound,	[S]	is	the	
concentration	of	starch	and	Kd	is	the	dissociation	constant.		
Affinity	electrophoresis	
To	investigate	binding	of	CBMs	to	amylose,	amylopectin,	glycogen,	pullulan	and	dextran,	affinity	
electrophoresis	was	used	(Abbott	&	Boraston,	2012,	Cockburn	et	al.,	2017).	Native	polyacrylamide	gels	
with	and	without	added	polysaccharide	were	compared	for	each	CBM	construct.	Binding	was	
considered	positive	if	the	migration	of	the	protein	in	the	polysaccharide	gel	relative	to	a	non-
interacting	protein	(bovine	serum	albumin)	was	significantly	slower	(<0.85	relative	mobility)	compared	
to	that	in	the	control	gel.	All	polysaccharides	were	used	at	0.1%	final	concentration.	Gels	were	made	at	
12%	acrylamide	with	0.375	M	Tris-HCl	pH	8.8.	Gels	were	subjected	to	100	V	for	4	h	and	then	stained	for	
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2	h	with	0.1%	Coomassie	Brilliant	Blue	R-250	in	10%	acetic	acid,	50%	methanol,	40%	water,	before	
destaining	with	solution	lacking	Coomassie	overnight	with	one	change	of	solution.		
Bioinformatic	analysis	
The	boundaries	of	the	CBMs	were	determined	from	examination	of	the	3-D	structures.	The	sequence	
corresponding	to	each	CBM	was	compared	to	the	sequences	of	the	CBM	families	listed	in	the	CAZy	
database	using	BLAST	(Altschul	et	al.,	1990).	
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Table	1:	Data	collection	and	refinement	statistics	for	Amy13K_CBMbc	and	Amy13K_CBMd	
	CBMbc	Native	 CBMbc	M7	 CBMd	
PDB	code	 6B15	 6B3P	 6AZ5	
Wavelength	 0.979	 0.979	 0.979	
Resolution	range	 36.02		-	2.1	(2.175		-	2.1)	
28.15		-	2.01	
(2.082		-	2.01)	
33.28		-	2.2	
(2.279		-	2.2)	
Space	group	 P	31	1	2	 P	65	2	2	 P	65	2	2	
Unit	cell	 131.73	131.73	151.87		90	90	120	
134.2	134.2	231.13		
90	90	120	
51	51	151.83		
90	90	120	
Molecules/ASU	 4	 2	 1	
Total	reflections	 557901	(55398)	 1264933	(124942)	 109448	(10683)	
Unique	reflections	 86483	(8664)	 81845	(7989)	 6492	(608)	
Multiplicity	 6.5	(6.4)	 15.5	(15.6)	 16.9	(17.6)	
Completeness	(%)	 98.46	(99.38)	 99.65	(99.37)	 99.94	(100.00)	
Mean	I/sigma(I)	 7.86	(2.03)	 10.90	(1.30)	 15.08	(9.98)	
Wilson	B-factor	 35.61	 31.84	 27.70	
R-merge	 0.09175	(0.5615)	 0.1781	(3.103)	 0.07451	(0.1759)	
R-meas	 0.09971	(0.6107)	 0.1841	(3.206)	 0.07692	(0.1812)	
R-pim	 0.03852	(0.237)	 0.04639	(0.8003)	 0.01875	(0.04297)	
CC1/2	 0.995	(0.832)	 0.997	(0.373)	 0.999	(0.996)	
CC*	 0.999	(0.953)	 0.999	(0.737)	 1	(0.999)	
Reflections	used	in	
refinement	 86454	(8666)	 81781	(7983)	 6492	(608)	
Reflections	used	for	R-free	 1992	(199)	 1998	(194)	 650	(61)	
R-work	 0.2080	(0.2749)	 0.1885	(0.2915)	 0.2336	(0.3189)	
R-free	 0.2318	(0.3235)	 0.2001	(0.2926)	 0.2566	(0.3106)	
CC(work)	 0.949	(0.780)	 0.960	(0.611)	 0.892	(0.811)	
CC(free)	 0.932	(0.666)	 0.949	(0.687)	 0.939	(0.774)	
Number	of	a oms	 7136	 4079	 968	
					Macromolecules	 6393	 3248	 920	
					Ligands	 12	 279	 0	
					Solvent	 731	 552	 48	
Protein	residues	 836	 418	 116	
RMS(bonds)	 0.003	 0.005	 0.004	
RMS(angles)	 0.77	 0.97	 0.85	
Ramachandran	favored	(%)	 95.53	 96.86	 96.49	
Ramachandran	allowed	(%)	 4.11	 3.14	 3.51	
Ramachandran	outliers	(%)	 0.36	 0.00	 0.00	
Rotamer	outliers	(%)	 0.75	 0.58	 0.00	
Clashscore	 0.33	 1.03	 0.57	
Average	B-factor	 44.18	 38.81	 26.18	
					Macromolecules	 44.06	 37.40	 26.06	
					Ligands	 52.53	 45.06	 	
					Solvent	 45.08	 43.93	 28.46	
Parentheses	indicate	statistics	for	the	highest	resolution	shell.		
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Table	2:	Binding	of	CBMs	to	oligosaccharides	and	glycogen	measured	by	ITC	
Construct	
Kd	(M)	±	SD	
β-cyclodextrin	 Maltoheptaose	 Glycogen	(mM/%))b	
CBMa	(n=1)a	 4.6	x10-4	±	7.4	x10-5	 1.0	x10-3	±	8.2	x10-5	 1.0	x10-4	±	8.2	x10-5	(2.3)	
CBMbc	(n=2)a	 3.7	x10-4	±	6.1	x10-5	 5.0	x10-4	±	7.0	x10-5	 3.0	x10-5	±	5.2	x10-6	(0.05)	
CBMde	(n=2)a	 1.0	x10-4	±	9.3	x10-5	 8.2	x10-6	±	2.3	x10-6	 2.4	x10-5	±	3.5	x10-6	(2.4)	
CBMe	(n=1)a	 8.5	x10-4	±	3.2	x10-4	 3.1	x10-3	±	9.7	x10-4	 6.0	x10-4	±	3.8	x10-4	(0.8)	
CBMb-e	(n=4)a	 7.8	x10-5	±	9.8	x10-6	 8.4	x10-5	 6.8	x10-7	±	3.4	x10-7	(0.06)	
CBMa-e	(n=5)a	 9.6	x10-5	±	2.9	x10-5	 3.1	x10-5	 3.4	x10-7	±	5.4	x10-8	(0.1)	
a	To	obtain	binding	affinity	it	was	necessary	to	fix	the	value	of	n.	Values	were	chosen	to	reflect	the	
number	of	CBMs	present	in	the	construct	b	The	mM/%	values	in	parentheses	represent	the	
concentration	of	binding	sites	in	1%	glycogen	for	this	construct,	see	Experimental	Procedures	
Table	3:	Binding	of	CBMs	to	insoluble,	intact	starch	granules	measured	by	depletion	assay	
Construct	
Kd	(mg/mL)	±	SD	
HiMaize	260	 Corn	Starch	 Potato	Starch	 Fibersym	
CBMa	 44.6	±			7.2	 		23.3	±			9.3	 NBa	 NBa	
CBMbc	 32.5	±			6.8	 102.3	±	35.8	 NBa	 NBa	
CBMde	 35.2	±	26.2	 		31.0	±			7.9	 NBa	 NBa	
CBMb-e	 		4.6	±			1.4	 		15.9	±			2.9	 NBa	 81.9	±	17.5	
CBMa-e	 14.2	±			8.0	 		20.7	±			4.4	 >	100b	 40.4	±	18.6		
a	No	significant	binding	detected	for	the	range	of	concentrations	used	in	this	assay	b	Binding	detected,	
but	did	not	exhibit	saturation	within	the	concentration	range	tested	
Table	4:	Activity	of	Amy13K	towards	soluble,	insoluble	and	resistant	starch	
Construct	
kcat/KM	(s-1	mg-1	mL)	±	SD	
Amylopectin	 Corn	Starch	 HiMaize	260	 Potato	Starch	
WT	 3.1	x102	±	1.8	x101	 3.8	x10-1	±	3.7	x10-2	 7.0	x10-1	±	2.8	x10-1	 7.7	x10-2	±	3.3	x10-3	
ΔCBMa	 2.3	x102	±	9.5	x101	 8.2	x10-2	±	1.0	x10-2	 1.6	x10-1	±	2.8	x10-2	 3.6	x10-2	±	1.0	x10-3	
ΔCBMa-c	 1.2	x102	±	1.0	x101	 1.4	x10-2	±	6.7	x10-4	 3.6	x10-2	±	1.5	x10-3	 1.9	x10-2	±	2.4	x10-3	
ΔCBMa-e	 1.2	x102	±	4.0	x101	 9.2	x10-3	±	1.5	x10-3	 1.8	x10-2	±	1.3	x10-3	 1.5	x10-2	±	4.2	x10-4	
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Figure	1.	Domain	organization	of	Amy13K.	The	signal	sequence	and	cell	wall	anchor	are	indicated	in	
grey,	CBMs	are	indicated	in	green	and	the	catalytic	domain	is	indicated	in	red.	The	numbers	along	the	
length	of	the	protein	represent	the	start	points	of	the	domains.	CBM	containing	constructs	and	
enzymatic	constructs	used	within	this	study	are	shown	below.	CBM	constructs	were	designed	based	
upon	a	bioinformatic	analysis	of	where	the	start	and	end	points	of	the	CBMs	could	be	reasonably	
predicted.	At	the	top,	the	CAZy	classification	for	each	CBM,	including	two	new	families	designated	as	
CBMxy	and	CBMyz,	is	noted.		
Figure	2.	Crystal	structure	of	Amy13K	CBM41d.	A)	Cartoon	diagram	of	Amy13K_CBMd	(PDB	6AZ5).	The	
putative	binding	site	residues	are	shown	in	green	and	the	tryptophans	of	the	binding	site	are	labeled	
for	orientation	purposes.	B)	An	overlay	of	the	carbohydrate	binding	sites	of	Amy13K_CBMd	and	the	
CBM41	from	T.	maritima	pullulanase	PulA	(PDB	2J73).	CBMd	binding	residues	and	labels	are	shown	in	
green,	while	PulA	CBM41	binding	residues,	bound	carbohydrate	and	labels	are	shown	in	blue.		
Figure	3.	Crystal	structures	of	Amy13K_CBMbc.	A)	Cartoon	diagram	of	Amy13K_CBMbc	in	complex	with	
maltoheptaose	(PDB	6B3P)	with	the	carbohydrate	chain	shown	in	green.	B)	A	close-up	view	of	the	
CBMb	oligosaccharide	binding	site.	The	sugar	chain	is	shown	in	dark	green	and	hydrogen	bonds	are	
indicated	by	dashed	lines.	C)	A	close-up	view	of	the	CBMc	oligosaccharide	binding	site.	The	sugar	chain	
is	shown	in	dark	green	and	hydrogen	bonds	are	indicated	by	dashed	lines.	D)	An	overlay	of	
Amy13K_CBMb	and	the	CBM26	from	Bacillus	halodurans	α-amylase	G6	(PDB	2C3H).	CBMb	residues	and	
bound	carbohydrate	are	shown	in	green,	while	those	for	the	B.	halodurans	CBM26	are	shown	in	aqua.		
E)	An	overlay	of	the	carbohydrate	binding	sites	of	Amy13K_CBMb	and	the	CBM26	from	B.	halodurans	
α-amylase	G6	(PDB	2C3H).	CBMb	residues,	carbohydrate	and	labels	are	shown	in	green,	while	those	for	
CBM26	are	shown	in	blue.			
Figure	4.	Affinity	electrophoresis	of	Amy13K	CBMs.	Proteins	are	separated	with	(right)	or	without	(left)	
the	indicated	polysaccharide	incorporated	into	the	gel	at	0.1%	final	concentration	in	native-PAGE.	
Bovine	serum	albumin	(BSA)	was	loaded	as	a	non-binding	control.		
	
	
	
Page 36 of 40Molecular Microbiology
This article is protected by copyright. All rights reserved.
A
cc
ep
te
d 
A
rt
ic
le
  
 
 
Domain organization of Amy13K. The signal sequence and cell wall anchor are indicated in grey, CBMs are 
indicated in green and the catalytic domain is indicated in red. The numbers along the length of the protein 
represent the start points of the domains. CBM containing constructs and enzymatic constructs used within 
this study are shown below. CBM constructs were designed based upon a bioinformatic analysis of where the 
start and end points of the CBMs could be reasonably predicted. At the top, the CAZy classification for each 
CBM, including two new families designated as CBMxy and CBMyz, is noted.  
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Figure 2. Crystal structure of Amy13K CBM41d. A) Cartoon diagram of Amy13K_CBMd (PDB 6AZ5). The 
putative binding site residues are shown in green and the tryptophans of the binding site are labeled for 
orientation purposes. B) An overlay of the carbohydrate binding sites of Amy13K_CBMd and the CBM41 from 
T. maritima pullulanase PulA (PDB 2J73). CBMd binding residues and labels are shown in green, while PulA 
CBM41 binding residues, bound carbohydrate and labels are shown in blue.  
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Figure 3. Crystal structures of Amy13K_CBMbc. A) Cartoon diagram of Amy13K_CBMbc in complex with 
maltoheptaose (PDB 6B3P) with the carbohydrate chain shown in green. B) A close-up view of the CBMb 
oligosaccharide binding site. The sugar chain is shown in dark green and hydrogen bonds are indicated by 
dashed lines. C) A close-up view of the CBMc oligosaccharide binding site. The sugar chain is shown in dark 
green and hydrogen bonds are indicated by dashed lines. D) An overlay of Amy13K_CBMb and the CBM26 
from Bacillus halodurans α-amylase G6 (PDB 2C3H). CBMb residues and bound carbohydrate are shown in 
green, while those for the B. halodurans CBM26 are shown in aqua.  E) An overlay of the carbohydrate 
binding sites of Amy13K_CBMb and the CBM26 from B. halodurans α-amylase G6 (PDB 2C3H). CBMb 
residues, carbohydrate and labels are shown in green, while those for CBM26 are shown in blue.    
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Figure 4. Affinity electrophoresis of Amy13K CBMs. Proteins are separated with (right) or without (left) the 
indicated polysaccharide incorporated into the gel at 0.1% final concentration in native-PAGE. Bovine serum 
albumin (BSA) was loaded as a non-binding control.  
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